ArticleBMC cancer2026

Real-world efficacy of first- and second-generation EGFR TKIs in NSCLC with EGFR co-mutations: a Vietnamese cohort study.

Luong Van Dinh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.